These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 24529902)
1. Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Wang Y; Liu T; Zhang E; Luo S; Tan X; Shi C Biomaterials; 2014 Apr; 35(13):4116-24. PubMed ID: 24529902 [TBL] [Abstract][Full Text] [Related]
2. A multifunctional heptamethine near-infrared dye for cancer theranosis. Luo S; Tan X; Qi Q; Guo Q; Ran X; Zhang L; Zhang E; Liang Y; Weng L; Zheng H; Cheng T; Su Y; Shi C Biomaterials; 2013 Mar; 34(9):2244-51. PubMed ID: 23261220 [TBL] [Abstract][Full Text] [Related]
3. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Zhang C; Liu T; Su Y; Luo S; Zhu Y; Tan X; Fan S; Zhang L; Zhou Y; Cheng T; Shi C Biomaterials; 2010 Sep; 31(25):6612-7. PubMed ID: 20542559 [TBL] [Abstract][Full Text] [Related]
4. A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties. Tan X; Luo S; Wang D; Su Y; Cheng T; Shi C Biomaterials; 2012 Mar; 33(7):2230-9. PubMed ID: 22182749 [TBL] [Abstract][Full Text] [Related]
5. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592 [TBL] [Abstract][Full Text] [Related]
6. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681 [TBL] [Abstract][Full Text] [Related]
7. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109 [TBL] [Abstract][Full Text] [Related]
8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998 [TBL] [Abstract][Full Text] [Related]
9. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Yue C; Liu P; Zheng M; Zhao P; Wang Y; Ma Y; Cai L Biomaterials; 2013 Sep; 34(28):6853-61. PubMed ID: 23777910 [TBL] [Abstract][Full Text] [Related]
10. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Peer D; Dekel Y; Melikhov D; Margalit R Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283 [TBL] [Abstract][Full Text] [Related]
11. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment. Kumar R; Han J; Lim HJ; Ren WX; Lim JY; Kim JH; Kim JS J Am Chem Soc; 2014 Dec; 136(51):17836-43. PubMed ID: 25402959 [TBL] [Abstract][Full Text] [Related]
13. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway. Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effect and mechanism of sulfate polysaccharide of algae on lung cancer]. Zhai ZG; Jiang HD; Qin XM; Wang C Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):97-100. PubMed ID: 14990183 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent. Zhang E; Luo S; Tan X; Shi C Biomaterials; 2014 Jan; 35(2):771-8. PubMed ID: 24148240 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria targeting and near-infrared fluorescence imaging of a novel heptamethine cyanine anticancer agent. Ning J; Huang B; Wei Z; Li W; Zheng H; Ma L; Xing Z; Niu H; Huang W Mol Med Rep; 2017 Jun; 15(6):3761-3766. PubMed ID: 28440435 [TBL] [Abstract][Full Text] [Related]
17. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells. Magesh V; Lee JC; Ahn KS; Lee HJ; Lee HJ; Lee EO; Shim BS; Jung HJ; Kim JS; Kim DK; Choi SH; Ahn KS; Kim SH Phytother Res; 2009 Oct; 23(10):1385-91. PubMed ID: 19277950 [TBL] [Abstract][Full Text] [Related]
18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
19. Clitocine targets Mcl-1 to induce drug-resistant human cancer cell apoptosis in vitro and tumor growth inhibition in vivo. Sun JG; Li H; Li X; Zeng X; Wu P; Fung KP; Liu FY Apoptosis; 2014 May; 19(5):871-82. PubMed ID: 24563182 [TBL] [Abstract][Full Text] [Related]
20. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models. Lee CH; Yao CF; Huang SM; Ko S; Tan YH; Lee-Chen GJ; Wang YC Cancer; 2008 Aug; 113(4):815-25. PubMed ID: 18618576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]